Thrombolysis in endovascular management of chronic aortic occlusions: A narrative review
DOI:
https://doi.org/10.48750/acv.681Keywords:
CERAB, Bare-metal stent, Aortoiliac occlusive disease, Peripheral arterial disease, Catheter-directed thrombolysisAbstract
INTRODUCTION: Revascularisation of chronic juxtarenal aortic occlusions can present a complex challenge. While open repair remains the gold standard, endovascular therapy is increasingly used in high- risk patients. The role of catheter- directed thrombolysis (CDT) in chronic aortic occlusions remains unclear and might be underestimated in patients unfit for open revascularisation.
METHODS: We conducted a narrative review of PubMed/MEDLINE and Embase for English- language studies from January 1, 2000, to January 31, 2025. Using MeSH and free- text terms for thrombolysis (e.g., catheter- directed thrombolysis, fibrinolysis, urokinase, tissue plasminogen activator) and chronic aortic/aroilial occlusion (including juxtarenal/infrarrenal anatomy), we included native chronic aortic or aortoiliac occlusions treated with CDT in revascularisation studies reporting technical and/or clinical outcomes. Case reports (<5 patients) were excluded. Outcomes assessed included technical success (thrombus reduction enabling definitive endovascular therapy), patency, and major complications.
RESULTS: Five retrospective series were included, comprising 54 patients treated with CDT (urokinase or tPA) before endovascular aortoiliac revascularisation. All studies used CDT as an adjunct to endovascular revascularisation. Technical success rates ranged from 80 - 100%, with no 30- day mortality and low complication rates. Reported primary patency after definitive endovascular reconstruction was generally 85 - 100% at 1 year (83% at 18 months in one series), with limited longer- term follow- up.
CONCLUSION: CDT may serve as a useful adjunct in the endovascular treatment of chronic juxtarenal aortic occlusions, particularly in high- risk patients. However, further prospective studies are needed to define its long- term efficacy and safety.
Downloads
References
Dorigo W, Piffaretti G, Benedetto F, Tarallo A, Castelli P, Spinelli F, et al. A comparison between aortobifemoral bypass and aortoliac kissing stents in patients with complex aortoliac obstructive disease. J Vasc Surg. 2017;65:99-107
Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. Eur J Vasc Endovasc Surg. 2019;58:S1-S109
Dotter CT, Rosch J, Seaman AJ. Selective clot lysis with low dose streptokinase. Radiology. 1974;111:31-7
Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg. 1994;220:251-66
Kim TH, Ko YG, Kim U, Kim JS, Choi D, Hong MK, et al. Outcomes of endovascular treatment of chronic total occlusion of the infranearal aorta. J Vasc Surg. 2011;53:1542-9
Moise MA, Alvarez-Tostado JA, Clair DG, Greenberg RK, Lyden SP, Srivastava SD, et al. Endovascular management of chronic infranearal aortic occlusion. J Endovasc Ther. 2009;16:84-92
Zhang F, Zhang H, Luo X, Liang G, Feng Y, Zhang WW. Catheter-directed thrombolysis-assisted angioplasty for chronic lower limb ischemia. Ann Vasc Surg. 2014;28:590-5
Yuan L, Bao J, Zhao Z, Feng X, Lu Q, Jing Z. Endovascular therapy for long-segment atherosclerotic aortoliac occlusion. J Vasc Surg. 2014;59:663-8
Zhao J, Li W, Zhang X, Zhang X, Li Q, Jiao Y. Catheter-directed thrombolysis to treat juxtarenal aortic occlusion. Int J Clin Exp Med 2020;13:1949-54.
Minion DJ. Lysis and covered endovascular reconstruction of the aortic bifurcation (LA CERAB) technique for chronic juxtarenal aortic occlusions. J Cardiovasc Surg. 2023;64:389-95.
Ebben HP, Jongkind V, Wisselink W, Hoksbergen AWJ, Yeung KK. Catheter Directed Thrombolysis Protocols for Peripheral Arterial Occlusions: a Systematic Review. Eur J Vasc Endovasc Surg 2019;57:667-75.
